224 related articles for article (PubMed ID: 19503102)
41. PPAR-α agonists acutely inhibit Ca
Chen H; Man RYK; Leung SWS
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H681-H691. PubMed ID: 29127234
[TBL] [Abstract][Full Text] [Related]
42. Long-term ACE inhibition doubles lifespan of hypertensive rats.
Linz W; Jessen T; Becker RH; Schölkens BA; Wiemer G
Circulation; 1997 Nov; 96(9):3164-72. PubMed ID: 9386189
[TBL] [Abstract][Full Text] [Related]
43. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
[TBL] [Abstract][Full Text] [Related]
44. Endothelial-derived extracellular vesicles from obese/hypertensive adults increase factors associated with hypertrophy and fibrosis in cardiomyocytes.
Fandl HK; Garcia VP; Treuth JW; Brewster LM; Greiner JJ; Davy KP; Stauffer BL; Desouza CA
Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H675-H685. PubMed ID: 36930654
[TBL] [Abstract][Full Text] [Related]
45. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
[TBL] [Abstract][Full Text] [Related]
46. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
[TBL] [Abstract][Full Text] [Related]
47. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
48. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.
Liang C; Ren Y; Tan H; He Z; Jiang Q; Wu J; Zhen Y; Fan M; Wu Z
Br J Pharmacol; 2009 Dec; 158(8):1865-73. PubMed ID: 19917066
[TBL] [Abstract][Full Text] [Related]
49. Hypertension augments cardiac Toll-like receptor 4 expression and activity.
Eissler R; Schmaderer C; Rusai K; Kühne L; Sollinger D; Lahmer T; Witzke O; Lutz J; Heemann U; Baumann M
Hypertens Res; 2011 May; 34(5):551-8. PubMed ID: 21248757
[TBL] [Abstract][Full Text] [Related]
50. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
51. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
52. The dipeptidyl peptidase-4 inhibitor-sitagliptin modulates calcium dysregulation, inflammation, and PPARs in hypertensive cardiomyocytes.
Lee TI; Kao YH; Chen YC; Huang JH; Hsu MI; Chen YJ
Int J Cardiol; 2013 Oct; 168(6):5390-5. PubMed ID: 24012160
[TBL] [Abstract][Full Text] [Related]
53. Metformin prevents the development of chronic heart failure in the SHHF rat model.
Cittadini A; Napoli R; Monti MG; Rea D; Longobardi S; Netti PA; Walser M; Samà M; Aimaretti G; Isgaard J; Saccà L
Diabetes; 2012 Apr; 61(4):944-53. PubMed ID: 22344560
[TBL] [Abstract][Full Text] [Related]
54. In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy.
He T; Chen L; Chen Y; Han Y; Yang WQ; Jin MW
Cardiovasc Drugs Ther; 2012 Apr; 26(2):109-20. PubMed ID: 22183794
[TBL] [Abstract][Full Text] [Related]
55. Cardiac Protective Effects of Moringa oleifera Seeds in Spontaneous Hypertensive Rats.
Randriamboavonjy JI; Loirand G; Vaillant N; Lauzier B; Derbré S; Michalet S; Pacaud P; Tesse A
Am J Hypertens; 2016 Jul; 29(7):873-81. PubMed ID: 26864583
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
[TBL] [Abstract][Full Text] [Related]
57. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
[TBL] [Abstract][Full Text] [Related]
58. Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.
Gonon AT; Bulhak A; Labruto F; Sjöquist PO; Pernow J
Basic Res Cardiol; 2007 Jan; 102(1):80-9. PubMed ID: 16900441
[TBL] [Abstract][Full Text] [Related]
59. Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat.
Ochodnicky P; Mesarosova L; Cernecka H; Klimas J; Krenek P; Goris M; van Dokkum RP; Henning RH; Kyselovic J
Eur J Pharmacol; 2014 May; 730():51-60. PubMed ID: 24582928
[TBL] [Abstract][Full Text] [Related]
60. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.
Engle SK; Solter PF; Credille KM; Bull CM; Adams S; Berna MJ; Schultze AE; Rothstein EC; Cockman MD; Pritt ML; Liu H; Lu Y; Chiang AY; Watson DE
Toxicol Sci; 2010 Apr; 114(2):183-92. PubMed ID: 20044590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
